Fed’s Waller says U.S. economy is ‘ready to rip’

(Reuters) – The U.S. economy is set to take off as more Americans are vaccinated, the virus gets under control and consumers become more comfortable engaging in economic activity, Federal Reserve Governor Christopher Waller said on Friday. “I think the economy is ready to rip,” Waller said during an interview with CNBC. Waller said he expects the U.S. economy to grow by 6.5% this year, for inflation to rise by about 2.5% and for the unemployment rate to drop to about 5% by year end. The U.S. central bank slashed interest rates to near zero last year to bolster the economy as it was being hammered by the pandemic. Officials also say they will purchase $120 billion a month in bonds until there is “substantial further progress” toward the Fed’s goals for maximum employment and inflation. Waller said that despite the brighter outlook, the U.S. economy still has a long way to go before those targets are achieved. Unemployment rates for minority workers are still elevated, he said. And any price increases seen in the near term are likely to be short lived as bottlenecks caused by the pandemic are resolved and the bump in demand from stimulus checks fades.

“Whatever temporary surge in inflation we see right now is not going to last,” Waller said.

A new U.S. Fed index of inflation expectations hit 2.01% for the first quarter of 2021, the first time the quarterly measure has hit the Fed’s 2% target since mid-2018, according to an update released on Friday. Fed policymakers would be fine with having inflation run above the central bank’s 2% target for some time to make up for periods of undershooting the goal, he said. But officials would act if inflation stayed much higher than that. “We want it to be on average around 2%,” Waller said. “I don’t think anybody would be very comfortable if it got to three or three plus and stayed there for a while.”

Stimulus Check Update: More Payments Blasted Out

https://youtu.be/FkMj1VDojWY

Ever since the $1.9 trillion American Rescue Plan was signed into law in mid-March, the IRS has been working furiously to get stimulus payments out to the public — especially given the number of people who have been struggling financially during the ongoing pandemic. So far, more than $376 billion in funds has gone out in the form of physical checks, debit cards, and deposits made directly into recipients’ bank accounts. But some people who are eligible for a stimulus have still not received their money. Here’s where things stand. The IRS is sending out stimulus payments in large batches, and recently, it made its fifth blast. To date, an estimated 159 million recipients have received stimulus funds. The latest batch includes about 2 million checks that went out to Veterans Affairs beneficiaries who do not normally file a tax return and did not register for a stimulus payment with the IRS’s non-filer tool last year. Those beneficiaries received a total of about $450 million. Seniors on Social Security were also included in the recent batch payment. About 72,000 checks went out to beneficiaries who did not file a tax return for the past two years and who also didn’t use the IRS’s non-filer tool to register for a stimulus last year. Additionally, almost 850,000 payments worth about $1.6 billion went out to non-filers — people who didn’t submit a tax return over the past two years. Many lower income households generally aren’t required to file taxes, but in the absence of a return or registration on its non-filer site, the IRS has a harder time knowing how to track people down who are entitled to stimulus funds. Finally, the latest blast included plus-up payments for recipients who were due a larger stimulus than they initially got in light of the information contained on their 2020 tax returns. Though the IRS has now sent out multiple batches of stimulus checks and has managed to target a distinct number of groups, some people are still waiting on that money. The IRS is limited in the number of physical checks and debit cards it can issue at once, so some people who aren’t eligible for direct deposit may still be waiting on their stimulus to trickle in. If you haven’t gotten a stimulus check yet, you can use the IRS’s Get My Payment tool to see where it stands. But also, it could pay for you to get moving on your 2020 tax return if you haven’t filed it already. If your income was lower in 2020 than it was in 2019, that could render you eligible for a stimulus check — but until the IRS sees that, it won’t know that you’re entitled to a payment. Tax returns aren’t due until May 17 — the IRS postponed the filing deadline after the American Rescue Plan was signed into law. But if you want your stimulus sooner, then you may want to expedite your return.

Airbnb’s CEO says the company will need millions more hosts to deal with a post-pandemic travel boom ‘unlike anything we’ve ever seen’Airbnb’s CEO says the company will need millions more hosts to deal with a post-pandemic travel boom ‘unlike anything we’ve ever seen’

  • Airbnb’s CEO on Friday said it needed millions more hosts for the post-pandemic travel boom.
  • Airbnb sees a “rebound coming that’s unlike anything we’ve ever seen,” CEO Brian Chesky told CNBC.
  • It has 4 million hosts with about 5.6 million listings, numbers mostly unchanged by the pandemic.

Airbnb will need millions of new hosts to meet demand as the world exits the pandemic, CEO Brian Chesky told CNBC on Friday. “To meet the demand over the coming years, we’re going to need millions more hosts,” Chesky told the network’s Deirdre Bosa on air. As the world tiptoes out of the pandemic, travelers are taking their first steps towards normal vacation routines. Many are wondering if Airbnb accommodations and hotels are safe. Chesky said on Friday that Airbnb expected the industry to roar back. He told CNBC: “I think that we probably will have a high-class problem where there will probably be more guests coming to Airbnb than we’ll have hosts for, because … we think there’s going to be a travel rebound coming that’s unlike anything we’ve ever seen.” Airbnb lists 4 million hosts, at present. As of the end of last year, they had about 5.6 million active listings in more than 220 countries and regions, according to the San Francisco company’s filings with the Securities and Exchange Commission. Chesky’s positive outlook echoed past statements and filings from the company. In a late February filing, the company said its listings had remained steady at 5.6 million for the entirety of 2020, despite a decline in bookings because of the pandemic. The company said: “While we believe that travel will change as a result of COVID-19, the adaptability of our business suggests that we are well-positioned to serve this dynamic market as it continues to evolve and recover.” After a blockbuster December IPO, the company in February beat Wall Street’s Q4 expectations. But its $859 million in revenue was down 22% from the $1.1 billion reported in the same year-earlier period. Airbnb was “primed for recovery,” wrote Brian Nowak, a Morgan Stanley analyst, in a note sent to clients earlier this year. Nowak said he expected Airbnb to be the “only player growing” in the first quarter, versus its competitors, including Expedia and Booking Holdings. “Similar to ’20, when people are returning to travel, they are choosing local (in country/close to home, driving over flying) and more rural locations…which gives an edge to alternative accommodations,” Nowak said.

U.S. Housing Starts Rebounded in March

(Bloomberg) — U.S. housing starts rebounded sharply in March to the highest since 2006, exceeding forecasts and indicating residential construction is getting back on track after a winter storm-related setback. Residential starts jumped 19.4% last month to a 1.74 million annualized rate, according to government data released Friday. The median estimate in a Bloomberg survey called for a 1.61 million pace. Applications to build also climbed. The figures suggest that homebuilders are making progress on elevated construction backlogs stemming from both strong housing demand during the pandemic and inclement winter weather. While home sales have softened since October, they are still above pre-pandemic levels, indicating that construction activity will remain strong for some time. Federal Reserve Chair Jerome Powell said this week that most Fed policy makers don’t see raising interest rates until 2024, which should help keep mortgage rates low and support the housing market. Builders, nonetheless, are contending with rising construction materials prices, a challenging supply chain and limited availability of skilled workers. Those higher costs are contributing to soaring home prices that risk restraining demand. Applications to build, a proxy for future construction, increased 2.7% to an annualized 1.77 million units, while the number of one-family homes authorized for construction but not yet started — a measure of backlogs — rose to 124,000 in March, the most since May 2007. A report on Thursday showed a measure of homebuilder sentiment improved in April, suggesting firms see steady growth in the housing market heading into the second quarter. March data on both existing and new home sales will be released next week. Single-family starts rose 15.3% in March to an annualized 1.24 million, close to the highest since 2006Multifamily starts — which tend to be volatile and include apartment buildings and condominiums — increased 30.8%Construction rose in three of four regions, led by a surge in the Midwest and large gains in the Northeast and South The number of all types of homes authorized for construction but not yet started rose to 217,000 in March, the highest since August 2006

Americans are feeling the best they’ve felt since the pandemic began, consumer survey shows

Consumer sentiment index rose to 86.5 in April from 84.9 in the prior month, according to a preliminary survey by the University of Michigan

Stimulus checks, rising coronavirus vaccinations and a rapidly growing economy lifted the spirits of Americans in early April and pushed a closely followed survey of consumer attitudes to a 13-month high. The consumer sentiment index rose to 86.5 in April from 84.9 in the prior month, according to a preliminary survey by the University of Michigan. That’s the highest level since the pandemic erupted in the U.S. in March 2020. The index had touched a 16-year high of 101 just a month earlier. The attitude of Americans about their own personal finances and the broader economy right now also climbed to a 13-month high. The so-called index of current conditions rose to 97.2 from 93 in March. By comparison, the index stood at 114.8 in February 2020. A forward-looking gauge on what consumers expect six months from now, however, showed lingering anxiety about the pandemic, including the safety of coronavirus vaccines. The index was unchanged at 79.7. What also is playing into the anxiety of Americans is higher inflation. Consumers tend to notice higher prices initially through rising gasoline prices, which have climbed sharply since the end of last year. Consumers expect the rate of inflation, now at 2.6%, to increase to as high as 3.7%. The last time they expected such a relatively high rate of inflation was a decade ago. Yet like senior Federal Reserve officials, consumers expect inflation to taper off in the longer run to a 2.7% annual rate. On the brighter side, half of all those survey expect a decline in unemployment. That’s the highest percentage ever recorded, the University of Michigan said. The U.S. is surging again as government stimulus money flows into the economy, governments relax pandemic restrictions and businesses seek to hire in anticipation of strong sales in the months ahead. The government on Thursday reported a 10% increase in U.S. retail sales in March while unemployment claims sank almost 200,000 to a new pandemic low of 576,000. The only obstacle to growth? Another spike in coronavirus cases. The number of people catching the virus is no longer declining, but it hasn’t risen very much, either. So long as the virus remains contained, the economy should keep building momentum. “Increasingly widespread rollout of vaccines is clearly having a beneficial impact on consumer sentiment and confidence,” said chief economist Joshua Shapiro of MFR Inc.

Pfizer CEO: Third shot may be needed after 12 months

The head of the Pfizer pharmaceutical company has warned that people will probably need a third dose of his laboratory’s Covid-19 shot within six to 12 months of vaccination, adding that annual booster shots may also be required. The Pfizer chief has defended the relatively higher cost of the treatment. Speaking in an interview on American television, Pfizer CEO, Albert Bourla, said that his company was currently evaluating long-term vaccination needs, but that a third dose and annual revaccination were a “likely scenario”. “We need to see what would be the sequence, and for how often we need to do that, that remains to be seen,” Bourla told CBC. The whole situation needs to be confirmed, he said, adding that variants will play a “key role”. “It is extremely important to suppress the pool of people that can be susceptible to the virus,” he said. Researchers currently don’t know for how long vaccines will provide protection against the coronavirus. Pfizer published a study earlier this month claiming that its jab is more than 91 percent effective at protecting against the coronavirus, and more than 95 percent effective against severe cases of Covid-19 for up to six months after the second dose. But researchers say more data is needed to determine whether protection lasts beyond six months. David Kessler, the head of US President Joe Biden’s Covid-19 response team, warned a congressional committee on Thursday that Americans should expect to receive booster shots to defend against coronavirus variants. “We don’t know everything at this moment,” he told the House Coronavirus Crisis Subcommittee. “We are studying the durability of the antibody response. “It seems strong but there is some waning of that and no doubt the variants challenge” that, he said. “I think for planning purposes, planning purposes only, I think we should expect that we may have to boost.” Bourla also on Thursday defended the price of his company’s vaccine, saying the product is saving lives and will not be sold to poor countries for a profit. “Vaccines are very expensive,” Bourla said in an interview with several European news outlets. “They save human lives, they allow economies to reopen, but we sell them at the price of a meal,” he was quoted as saying.

Anti-parasitic drug kills coronavirus within 48 hours in lab grown cells: Study

According to the study, published in the journal Antiviral Research, the drug, Ivermectin, stopped the virus, SARS-CoV-2, from growing in cell culture within 48 hours. Researchers have found that an anti-parasitic drug already available around the world can kill the novel coronavirus grown in cell cultures within 48 hours, an advance that may lead to the development and trial of a new clinical therapy for COVID-19. According to the study, published in the journal Antiviral Research, the drug, Ivermectin, stopped the virus, SARS-CoV-2, from growing in cell culture within 48 hours.

“We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it,” said study co-author Kylie Wagstaff from Monash University in Australia.

The scientists said Ivermectin is an approved anti-parasitic drug that has also been shown to be effective in vitro against a broad range of viruses including HIV, Dengue, Influenza and Zika virus. However, Wagstaff cautioned that the tests conducted in the study were in vitro and that trials needed to be carried out in people. “Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective – that’s the next step,” Wagstaff said. “In times when we’re having a global pandemic and there isn’t an approved treatment, if we had a compound that was already available around the world then that might help people sooner,” she said. Although the mechanism by which Ivermectin works on the virus is not known, the scientists said it is likely, based on its action in other viruses, that it works to stop the virus ‘dampening down’ the host cells’ ability to clear it. “As the virologist who was part of the team who were first to isolate and share SARS-COV2 outside of China in January 2020, I am excited about the prospect of Ivermectin being used as a potential drug against COVID-19,” said Leon Caly, study co-author from the Royal Melbourne Hospital in Australia. The scientists further cautioned that the use of Ivermectin to combat COVID-19 would depend on the results of future pre-clinical testing and ultimately clinical trials

Powell: Economy likely to grow much more quickly

The U.S. economy is ready to take off, U.S. Federal Reserve Chairman Jerome Powell said Sunday. In an interview with CBS News’ “60 Minutes,” which released a snippet Sunday morning, Powell said increased growth should create more jobs. The full interview will air Sunday night at 7 p.m. Eastern on CBS. “What we’re seeing now is really an economy that seems to be at an inflection point,” Powell said in the interview. “We feel like we’re at a place where the economy’s about to start growing much more quickly and job creation coming in much more quickly.” Powell credited widespread vaccinations and strong fiscal-policy support through the pandemic, but warned that the economy could suffer a setback if there’s another wave of COVID-19 infections. “It’s going to be smart if people can continue to socially distance and wear masks,” he said.

It’s NOT the National Debt….. Stupid!

(Bloomberg) — Economics used to offer lots of metrics that claimed to show when growing economies were approaching some kind of speed limit. But increasingly, inflation is the only one that’s taken seriously.A lasting surge in prices would likely convince policy makers that it’s time to tap the brakes on expansionary measures adopted in the pandemic, like high public spending or low borrowing costs. That’s why Tuesday’s consumer-price data in the U.S. will be so closely watched — though it’ll take more than a single month’s numbers to change minds.

Meanwhile — as part of a profound shift in economic thinking that’s gathered pace in the past year — a whole range of other indicators once relied on to flag trouble ahead are falling out of favor.

Budget deficits and public debt were thought to flash a warning sign at certain levels — until plenty of countries exceeded those limits, especially in the last year, without crashing. Estimates for full employment, or the most jobs an economy could create without overheating, turned out to be wrong. Measures of the so-called “output gap” are supposed to capture how close an economy has gotten to its maximum capacity — but many analysts have concluded that they rely too much on the recent past to be a useful guide. Abandoning or downplaying all of these yardsticks means officials are less likely to take the kind of pre-emptive action that’s choked off expansions in the past.The shift also amounts to a pivot toward humility, in a profession not famous for it. Economists used to be comfortable with offering their predictions as a basis for policy. They’re having to acknowledge that the future is full of things they simply do not know.“The influence of long-term projections has evaporated, and that’s a very good thing,” says James Galbraith, a professor of economics at the University of Texas. “You design policies to deal with the problems you have. If they have consequences later, you address them later.” That philosophy underpins the Federal Reserve’s new interest-rate framework. Last decade, the central bank began raising borrowing costs even though inflation was subdued and unemployment was still around 5% post-financial crisis. Now, Fed officials effectively concede that was a mistake, because lower unemployment didn’t trigger a spike in prices. And now they say they’ll base policy on what’s actually happened in the economy, rather than what’s expected to come next. Three times in a speech last month, Federal Reserve Governor Lael Brainard contrasted “outcomes” with the “outlook” -– and said Fed policy will be based on the former, not the latter. In fiscal policy too, there’s been a rethink of speed limits.Budget deficits and national debt as a share of the economy used to be the go-to metrics. The European Union imposed 3% deficit caps. Economists Carmen Reinhart and Ken Rogoff, in an influential study a decade ago, argued that debt at 90% of GDP was a dangerous tipping point. This kind of thinking led to austerity policies after the initial shock of the 2008 financial crisis — and the result was a weak recovery. But budget forecasts tended to be too pessimistic because they didn’t anticipate that interest rates would remain low. In the pandemic, governments have been more willing to spend, especially in the U.S. President Joe Biden is pushing measures worth more than $5 trillion during his first year –- fuel for what already looks set to be a faster rebound in the economy. In some ways, the new approach aligns with the school of thought called Modern Monetary Theory. MMT says governments have room to rev up their economies with fiscal spending, and argues that inflation — rather than deficit or debt levels — is the metric that budget authorities need to keep their eye on.“One thing the mainstream has caught on to is allowing the economy to run a bit hotter,” says Scott Fullwiler, an MMT economist and associate professor at the University of Missouri-Kansas City. “That’s the thing we’ve been hitting on for decades.”Unfortunately, says Fullwiler, economists haven’t devoted enough attention to the question of what a safe maximum speed would be — and have focused too much on central banks, even though it’s now fiscal policy that is driving recoveries.“The economics profession in general has far and away enough capacity to figure out how hot the economy can run,” he says. It would have better answers right now “if economists had been working on fiscal-policy frameworks for stabilizing the economy and keeping inflation low, instead of optimal monetary policy, which is basically irrelevant.” In the U.S., opponents of Biden’s spending have invoked the “output gap” — the difference between the goods and services an economy is actually producing, and the maximum it could sustainably manage. Former Treasury Secretary Larry Summers and the Committee for a Responsible Federal Budget, for example, both argued that last month’s stimulus bill was much bigger than what was needed to close that shortfall — and risked triggering inflation as a result.But many analysts are skeptical about the measure. Robin Brooks, chief economist at the Institute of International Finance, has been leading a campaign against “nonsense output gaps” for years.The output gap is “a massively important concept” that underlies all the big policy calls, he says. “Nobody has any clue about how to measure it.” Output gaps rely on estimates of an economy’s potential. A small shortfall means production is reckoned to be getting close to its speed limits, and trying to make it go faster could set off inflation. But Brooks says that potential is often calculated simply by looking at what happened in the recent past. He says that when a country has been under-performing for an extended period, like Italy in recent decades, the result is that its potential gets downgraded too — effectively putting a cap on how good things should be allowed to get. In a February report, Goldman Sachs economists tried an alternative way of measuring, and concluded that output gaps in major economies from Italy to the U.S. were likely bigger at the end of last year than official estimates suggested — meaning that there was “more slack,” less risk of inflation and a stronger case for expansionary policy. Since then, the U.S. recovery has gained pace, surprising many analysts. Galbraith, who was director of the Joint Economic Committee of Congress during the recession of the early 1980s, says emergencies aren’t the right time for policy makers to attempt any kind of precision forecasts.“You don’t try to calculate these things,” he says. “You throw at it as much as you need, and more. And then, if it turns out that you’re doing too much — which is improbable — you scale it back.”

Real-world Israeli study shows SA variant can break through Pfizer vaccine

Researchers say highlights need to properly monitor for mutations entering Israel through the airport

The Pfizer coronavirus vaccine is somewhat less effective against the South African mutation; a new study has shown, raising a red flag among health professionals of the need to continue monitoring Israel’s airports to keep out what could be dangerous mutations. The study, conducted by Clalit Health Services and Tel Aviv University, was the first of its kind based on real-world data. It has been published on the MedRxiv online site and therefore has not yet been peer-reviewed. “The results indicate the need for genetic sequencing and constant monitoring for new variants, as well as continued implementation of non-pharmaceutical measures,” said Clalit’s Dr. Doron Netzer, head of Community Medicine at Clalit, who helped lead the study. Lab studies have previously suggested that the South African variant could break through the protection provided by the Pfizer vaccine, but lab studies do not always hold up in real life.
The study counters a report released by Pfizer earlier this month that claimed the vaccine was 100% effective in preventing coronavirus among participants trialed in South Africa, where the mutation is prevalent.

In this case, what was shown in the lab turned out to also occur in real life, Prof. Adi Stern, of the Shmunis School of Biomedicine and Cancer Research at Tel Aviv University’s Faculty of Life Sciences, told The Jerusalem Post. The study seems to counter a report released by Pfizer earlier this month that claimed the vaccine was 100% effective in preventing coronavirus among participants from a trial in South Africa, where the mutation is prevalent. The report was released on Saturday night. This week, the Health Ministry plans to discuss allowing Israelis to go mask-free in open areas immediately after the Independence Day holiday that takes place on Thursday. Last week, the government voted to change airport regulations and allow non-Israelis to visit their first-degree relatives in the country. Since March 20, all Israeli citizens have been able to enter from abroad. Specifically, the researchers examined around 400 members of Clalit Health who tested positive for the virus 14 days or more after receiving the first dose of the vaccine in comparison to 400 unvaccinated people who caught corona, too. The cohorts were matched according to age, sector, gender and more.

The study showed that the South African variant is more likely to break through the vaccine’s protective effect, even after two doses have been administered and more than a week has passed.
All positive samples underwent genetic sequencing to determine with which variant each person was infected. Only 1% of the infected people had the South African variant. However, among individuals who had been infected after receiving two doses of the vaccine, the prevalence rate of those who had the South African variant was eight times higher than the rate in the unvaccinated matched individuals. This means that the Pfizer vaccine does not provide the same level of protection against the South African variant. However, because so few Israelis have been infected with it, the researchers said they were unable to assess the exact reduction in effectiveness. Stern suggested that the South African has less transmissibility than the original strain and certainly less than the British mutation – that has been shown to be as much as 70% more contagious than the original strain – and therefore has not managed to spread. “It can break through the vaccine, but it cannot spread efficiently, so that is the good news,” Stern said, noting that one possible explanation is that the extensive spread of the British variant blocked the spread of the South African variant.
The results of the study drive home the message that Israel “has to be super careful about airports,” Stern cautioned. “We are in a unique position in Israel now. The vaccines are working, and amazingly, we are the only country in the world where life is going back to normal. The main threat now is what will happen through airport importations.”
Stern said that anyone who enters Israel should be tested and, if they are sick, the country should sequence their results to find out what variant they bear. They should also be effectively isolated. “We don’t want to import masses of the South African variant and we don’t want to test how limited the transmissibility [of the variant] is in Israel,” Stern cautioned. The study also examined the effectiveness of the Pfizer vaccine against the British variant and, once again, showed that the vaccine works. However, in 250 partially vaccinated individuals – meaning they had only had one dose of the vaccine or less than a week had passed since the second dose – the rate of the British variant was disproportionately higher compared to unvaccinated persons. This means, Stern explained, that although some studies have shown a strong efficacy of the Pfizer vaccine even after the first dose, it takes two doses to combat the British variant most effectively. She said that this may explain why in December and January when so many Israelis started vaccinating it took longer than expected to bring down the country’s rate of infection.
“The findings signal that we cannot yet regard the pandemic as a thing of the past,” said Prof. Shay Ben-Shachar, head of Precision Medicine for Clalit Innovation. “It still remains important to continue social distancing and using masks.”